124 related articles for article (PubMed ID: 6975675)
1. Rosette-increasing factor (RIF) generated in vivo following PHA skin test.
Kubota M; Mikawa H
Clin Exp Immunol; 1981 May; 44(2):315-23. PubMed ID: 6975675
[TBL] [Abstract][Full Text] [Related]
2. Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA rosette formation.
Kubota M; Yoshida T; Shinomiya K; Mikawa H
Clin Exp Immunol; 1980 Jun; 40(3):602-10. PubMed ID: 7418268
[TBL] [Abstract][Full Text] [Related]
3. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
4. Modulation of E rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF).
Skibiński G; Zwoliński J; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1979; 27(4):475-80. PubMed ID: 117784
[TBL] [Abstract][Full Text] [Related]
5. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
[TBL] [Abstract][Full Text] [Related]
6. The active E rosette test: correlation with delayed cutaneous hypersensitivity.
Felsburg PJ; Edelman R; Bilman RH
J Immunol; 1976 Apr; 116(4):1110-4. PubMed ID: 1082906
[TBL] [Abstract][Full Text] [Related]
7. An immunosuppressive serum factor in widespread cutaneous dermatophytosis.
Sherwin WK; Ross TH; Rosenthal CM; Petrozzi JW
Arch Dermatol; 1979 May; 115(5):600-4. PubMed ID: 312623
[TBL] [Abstract][Full Text] [Related]
8. The E-rosette augmenting factor (E-RAF): aspects of clinical application.
Agbata AI; Kirkpatrick CH
Clin Exp Immunol; 1980 Feb; 39(2):321-7. PubMed ID: 6966991
[TBL] [Abstract][Full Text] [Related]
9. A study of the mechanism of lymphokine production and release.
Korcáková L; Smetana K; Svobodová J
Folia Biol (Praha); 1980; 26(2):140-4. PubMed ID: 6155295
[TBL] [Abstract][Full Text] [Related]
10. Monocyte regulation of lymphokine production in cancer patients.
Kowalczyk D; Ruggiero I; Zembala M
J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
[TBL] [Abstract][Full Text] [Related]
11. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
Karwowska W; Kunicka A
Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
[TBL] [Abstract][Full Text] [Related]
12. Rosette inhibitory factor (RIF) augments cyclic AMP generation by helper T lymphocytes.
Sanders GE; Perrillo RP
J Clin Lab Immunol; 1986 Jul; 20(3):133-6. PubMed ID: 3018254
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell responses to Trichophyton tonsurans: inhibition using the serum free medium Aim V.
Slunt JB; Taketomi EA; Platts-Mills TA
Clin Exp Allergy; 1997 Oct; 27(10):1184-92. PubMed ID: 9383259
[TBL] [Abstract][Full Text] [Related]
14. Active E rosette formation by human lymphoblasts.
Semenzato G; Amadori G; Sarasin P; Gasparotto G
Immunology; 1978 Apr; 34(4):721-4. PubMed ID: 309851
[TBL] [Abstract][Full Text] [Related]
15. In vitro response to rosette inhibition factor (RIF) and rosette restoring factor (RRF) of human lymphocyte after fractionation on a discontinuous density albumin gradient.
Wieczorek Z; Skibiński G; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1979; 27(4):481-6. PubMed ID: 117785
[TBL] [Abstract][Full Text] [Related]
16. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
17. Ability of an anti-T-cell serum to dissociate two features of cellular hypersensitivity in the guinea-pig.
Godfrey HP; Koch C
Immunology; 1980 Jun; 40(2):247-53. PubMed ID: 6967855
[TBL] [Abstract][Full Text] [Related]
18. Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus.
Kumagai S; Sredni B; House S; Steinberg AD; Green I
J Immunol; 1982 Jan; 128(1):258-62. PubMed ID: 6976374
[TBL] [Abstract][Full Text] [Related]
19. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
20. Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.
Roszman TL; Brooks WH
Clin Exp Immunol; 1980 Feb; 39(2):395-402. PubMed ID: 6966992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
